• FirefoxUpgrade to the new Firefox »
  •  Dow Up 1.53% Nasdaq Up 1.52%

    Arrowhead Research Corp. (ARWR)

    -NasdaqGS
    6.09 0.00(0.00%) 12:28PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:6.09
    Open:6.12
    Bid:6.08 x 900
    Ask:6.09 x 600
    1y Target Est:17.75
    Beta:3.16
    Earnings Date:Feb 2 - Feb 6 (Est.)
    Day's Range:5.95 - 6.15
    52wk Range:4.95 - 27.63
    Volume:779,230
    Avg Vol (3m):3,864,400
    Market Cap:333.01M
    P/E (ttm):N/A
    EPS (ttm):-1.25
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARWR

    Comparison

    Symbol% ChgMkt Cap
    ARWR 0.00%333.01M
    PENCUp 18.57%26.41M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):1,902.94
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-15) :-1.53
    Quarterly EPS Est (Dec-14) :-0.34
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):-0.53

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Research Corporation develops novel drugs to treat intractable diseases in the United States. The company’s principal product candidates comprise ARC-520, an RNAi-based therapeutic that is in Phase IIa clinical trial to treat chroni... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback